Sagimet Biosciences Inc. (SGMT)
4.18
0.02 (0.60%)
At close: Jan 15, 2025, 3:44 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -27.88M | -30.50M | -24.44M | -11.37M | -14.26M |
| Depreciation & Amortization | n/a | 130.00K | 134.00K | 124.00K | 1K |
| Stock-Based Compensation | 4.99M | 1.88M | 1.90M | 775.00K | 2.99M |
| Other Working Capital | -1.10M | 1.30M | -615.00K | 436.00K | -633.00K |
| Other Non-Cash Items | 98.00K | -85.00K | 883.00K | 104.00K | 168.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | -93.00K |
| Change in Working Capital | -978.00K | 4.21M | -55.00K | 75.00K | 645.00K |
| Operating Cash Flow | -23.77M | -24.49M | -21.71M | -10.42M | -10.55M |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | 20.00K | n/a |
| Purchase of Investments | -19.62M | -41.45M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 32.20M | 9.44M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -32.01M | n/a | 20.00K | -27.00K |
| Investing Cash Flow | 12.58M | -32.01M | n/a | 20.00K | -27.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | -3.36M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -3.51M | -73.00K | 9.74M | 68.89M | 21.85M |
| Financial Cash Flow | 86.17M | -73.00K | 9.74M | 68.89M | 18.48M |
| Net Cash Flow | 74.98M | -56.57M | -11.97M | 58.49M | 7.91M |
| Free Cash Flow | -23.77M | -24.49M | -21.71M | -10.42M | -10.55M |